1. Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes

   BEAt-DKD Consortium, Kammer, M., Heinzel, A., Willency, J. A., Duffin, K. L., Mayer, G., Simons, K., Gerl, M. J., Klose, C., Heinze, G., Reindl-Schwaighofer, R., Hu, K., Perco, P., Eder, S., Rosivall, L., Mark, P. B., Ju, W., Kretzler, M., McCarthy, M., Heerspink, H. L., Wiecek, A., Gomez, M. F. & Oberbauer, R., Dec-2019, In : Kidney International. 96, 6, p. 1381-1388 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Epidemiological Applications in -Omics Approaches

   Critselis, E. & Heerspink, H. L., 26-Jan-2018, Integration of Omics Approaches and Systems Biology for Clinical Applications. Wiley, p. 207-214 8 p.

   Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

3. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

   Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., Bornpoint, S., Levin, A. & Jardine, M. J., Nov-2019, In : Lancet Diabetes & Endocrinology. 7, 11, p. 845-854 10 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors

   Reijrink, M., de Boer, S. A., Spoor, D. S., Lefrandt, J. D., Lambers Heerspink, H. J., Boellaard, R., Greuter, M. J., Borra, R. J. H., Hillebrands, J-L., Slart, R. H. J. A. & Mulder, D. J., Nov-2019, In : ATHEROSCLEROSIS. 290, p. 87-93 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease

   Rossing, P., Block, G. A., Chin, M. P., Goldsberry, A., Heerspink, H. J. L., McCullough, P. A., Meyer, C. J., Packham, D., Pergola, P. E., Spinowitz, B., Sprague, S. M., Warnock, D. G. & Chertow, G. M., Oct-2019, In : Kidney International. 96, 4, p. 1030-1036 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (280) »

1. Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas

   Jasper Stevens (Speaker), Hiddo Heerspink (Speaker)

   29-Jan-2019

   Activity: Talk or presentation › Professional

2. Challenges with Personalized Medicine

   Hiddo Lambers Heerspink (Speaker)

   Oct-2018

   Activity: Talk or presentation › Professional

3. Invited lecture Annual Society of Japanese Diabetes Association

   Hiddo Lambers Heerspink (Speaker)

   Oct-2018

   Activity: Talk or presentation › Professional

View all (13) »